<div id="content">
				<a id="top"></a>
	        		        	<h1 id="firstHeading" class="firstHeading">Drugsandbrain:Lecture Notes 3</h1>
				<div id="bodyContent">
		            <h3 id="siteSub">From Coursera</h3>
		            <div id="contentSub"></div>
		            		            		            					<!-- start content -->
					<div lang="en" dir="ltr" class="mw-content-ltr"><table id="toc" class="toc"><tr><td><div id="toctitle"><h2>Contents</h2></div>
<ul>
<li class="toclevel-1"><a href="#Drugs_Bind_to_Neurotransmitter_Transporters_.2822.29"><span class="tocnumber">1</span> <span class="toctext">Drugs Bind to Neurotransmitter Transporters (22)</span></a></li>
<li class="toclevel-1"><a href="#Neurotransmitter_Transporters_as_Molecules_.2823.29"><span class="tocnumber">2</span> <span class="toctext">Neurotransmitter Transporters as Molecules (23)</span></a></li>
<li class="toclevel-1"><a href="#Recreational_Drugs:_Overview_.2824.29"><span class="tocnumber">3</span> <span class="toctext">Recreational  Drugs: Overview (24)</span></a></li>
<li class="toclevel-1"><a href="#Targets_.2825.29"><span class="tocnumber">4</span> <span class="toctext">Targets (25)</span></a></li>
<li class="toclevel-1"><a href="#System_level_effects_.2826.29"><span class="tocnumber">5</span> <span class="toctext">System level effects (26)</span></a></li>
<li class="toclevel-1"><a href="#Components_of_Addiction._Animal_Models._.2827.29"><span class="tocnumber">6</span> <span class="toctext">Components of Addiction.   Animal Models. (27)</span></a></li>
<li class="toclevel-1"><a href="#Nicotine_Addiction_at_the_circuit_and_cellular_level:_.E2.80.9COutside-In.E2.80.9D_Mechanisms_.2828.29"><span class="tocnumber">7</span> <span class="toctext">Nicotine Addiction at the circuit and cellular level: “Outside-In” Mechanisms (28)</span></a></li>
<li class="toclevel-1"><a href="#Upregulation_via_.E2.80.9CInside-Out.E2.80.9D_Mechanisms_.2829.29"><span class="tocnumber">8</span> <span class="toctext">Upregulation via “Inside-Out” Mechanisms (29)</span></a></li>
<li class="toclevel-1"><a href="#Recent_Genetic_Data_.2830.29"><span class="tocnumber">9</span> <span class="toctext">Recent Genetic Data (30)</span></a></li>
<li class="toclevel-1"><a href="#Drugs_for_smoking_cessation.3B_Harm_Reduction_.2831.29"><span class="tocnumber">10</span> <span class="toctext">Drugs for smoking cessation; Harm Reduction (31)</span></a></li>
</ul>
</td></tr></table>
<h1> <span class="mw-headline" id="Drugs_Bind_to_Neurotransmitter_Transporters_.2822.29">Drugs Bind to <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Neurotransmitter_transporter">Neurotransmitter Transporters</a> (22)</span></h1>
<p><strong>Serotonin pathways in the brain</strong>
<ul><li> <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Raphe_nuclei">Raphe nuclei</a> release serotonin to the rest of the brain.
</li><li> Raphe nuclei are in two systems
</li></ul>
  - Rostral and Caudal
<ul><li> Serotonergic means "related to the neurotransmitter serotonin".</p>
</li></ul>

<p><strong>3 classes of proteins transport ions across membranes</strong>
<ul><li> Passive Transport
</li></ul>
  - Channel Proteins<br />
  - Ion Coupled Transporter (play a major role in neurotransmitter transport)<br />
<ul><li> Active transport
</li></ul>
  - requires energy from ATP<br />
  - Ion Pumps (also important in neurotransmitter transport) </p>
<p><strong>Plasma Membrane neurotransmitter transport into cell</strong> 
<ul><li> ATP driven Sodium pump increases Sodium concentration in cell
</li><li> Sodium (Na+) coupled neurotransmitter transporter
</li></ul>
  (Sodium ions flow out of cell, neurotransmitter flows into cell
<ul><li> Process can be reversed
</li><li> Performs two major functions 
</li></ul>
<ol>
<li>Terminate action of Neurotransmitter</li>
<li>Replenish neurotransmitter in presynaptic terminal of neuron</li>
</ol></p>
<p><strong>Vesicle transport</strong> 
<ul><li> gets neurotransmitter into synaptic vesicles (SV)
</li><li> ATP driven Proton pump increases protons within SV
</li><li> proton coupled neurotransmitter transporter
</li></ul>
  (Protons flow out of SV, neurotransmitter flows into SV
<ul><li> Process can be reversed </p>
</li></ul>

<p><strong>MDMA or Amphetamines Release Transmitter into the External Medium</strong>
<ul><li> inhibits uptake of dopamine into presynaptic terminal
</li><li> causes release of dopamine (DA) from presynaptic terminals</p>
</li></ul>

<p><strong>Method to detect dopamine</strong>
<ul><li> Carbon-ﬁber electrodes can be used to make sensitive current measurements
</li><li> This method is called Cyclic voltammetry</p>
</li></ul>

<p><strong>Dopamine transporter (DAT) knockout mice experiment</strong>
<ul><li> Experiment to determine effect of amphetamine on normal mice and mice that lack dopamine transporter
</li><li> DAT knockout means deletion of a gene that expresses dopamine trasnporter protein
</li><li> Normal mice: after release of amphetamine there is a gradual increase of extracellular dopamine
</li><li> DAT knockout mice: after release of amphetamine; no change in extracellular dopamine   </p>
</li></ul>

<p><strong>Sodium (Na+) coupled cell membrane neurotransmitter transporter major targets for drugs of therapy and abuse</strong> 
<ul><li> serotonin transporter 
</li></ul>
- Antidepressants (Selective serotonin reuptake inhibitors or SSRI)<br />
- Recreational drug: MDMA 
<ul><li> dopamine transporter
</li></ul>
- Attention-deficit disorder (amphetamine)<br />
- Recreational drug: cocaine, amphetamines</p>
<hr />
<h1> <span class="mw-headline" id="Neurotransmitter_Transporters_as_Molecules_.2823.29">Neurotransmitter Transporters as Molecules (23)</span></h1>
<ul>
<li>discussion of neurotransmitter transporter as proteins</li>
<li>counting neurotransmitter transporter  </li>
</ul>
<p><strong>“Alternating Access” Model for ion-coupled transporters</strong>
<ul><li> How do ion coupled transporters work?
</li><li> Move an ion and a small molecule
</li><li> transporter protein "cycles" between two conformations which moves molecules between two compartments
</li><li> symport moves molecules to the same compartment
</li><li> antiport moves molecules to opposite compartments</p>
</li></ul>

<p><strong>Fluoxetine Bound to LeuT, a Bacterial Homologue of Neurotransmitter Transporters</strong>
<ul><li> the bacterial protein shown is a transporter that is analogous to neurotransmitter transporter 
</li><li> it is a static view, not dynamic</p>
</li></ul>

<p><strong><a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Selective_serotonin_reuptake_inhibitor">SSRIs</a> bind tightly to, and stabilize, intermediate state(s) of the serotonin transporter</strong>
<ul><li> The experiment describes the dynamics of the “Alternating Access” Model
</li><li> ion-coupled transporters behave like ion channel with gates on either end
</li><li> Sodium, potassium and chloride ions can be used
</li><li> Sometimes both gates can be stuck open - like an ion channel
</li><li> <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Selective_serotonin_reuptake_inhibitor">SSRIs</a>get the transporter "stuck", preventing it from functioning</p>
</li></ul>

<p><strong>The GAT1 inhibitor, tiagabine, is used for epilepsy.</strong>
<ul><li> one type GABA transporter is caled GAT1 
</li><li> tiagabine slows GAT1 transport of GABA, which prolongs lifetime of GABA, allows GABA inhibition to increase, decreasing neuron firing
</li><li> developed method to count GAT1</p>
</li></ul>

<p><strong><a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Cerebellum">cerebellum</a>, rich in GABA inhibition</strong>
<ul><li> Looked at molecular layer, <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Purkinje_cell">Purkinje cell layer</a>, and <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Granule_cell_(cerebellum)">granule cell layer</a></p>
</li></ul>

<p><strong>How to localize and quantify GABA transporters</strong>
<ul><li> Take the gene of GABA transporter and append <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Green_fluorescent_protein">green fluorescent protein (GFP)</a>
</li><li> the protein expressed is a GABA transporter that fluoresces green and can be counted</p>
</li></ul>

<p><strong>Brain of GABA Transporter-GFP ‘Knock-in” Mouse</strong>
<ul><li> need to make a strain of mice with the gene that has GABA transporter with GFP
</li><li> called a knock-in because a gene has been added
</li><li> GABA transporter with GFP expressed throughout mouse brain</p>
</li></ul>

<p><strong>GAT1-GFP expression in cerebellum</strong>
<ul><li> The highest density (most green) region of the cerebellum is at junction of basket cells and Purkinje cell layer
</li><li> this is the pinceaux region
</li><li> at the molecular level, there are about 1000 GABA transporter per square micron
</li><li> An example of how neuroscientists study the targets for drugs</p>
</li></ul>

<hr />
<h1> <span class="mw-headline" id="Recreational_Drugs:_Overview_.2824.29">Recreational  Drugs: Overview (24)</span></h1>
<ul>
<li>Apply what we learn to certain key classes of drug action</li>
</ul>
<p><strong>Recreational drugs</strong>
<ul><li> Recreational drugs are not equal to addictive drugs are not equal to abused drugs are not equal to illegal drugs
</li><li> but there is some overlaps
</li><li> We will study a constellation of nine drugs, mostly low molecular weight
</li><li> <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Morphine">morphine</a>, <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Tetrahydrocannabinol">tetrahydrocannabinol</a>, <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Ethanol">ethanol</a><br />
</li><li> <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Caffeine">caffeine</a>, <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Phencyclidine">phencyclidine</a>, <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/LSD">LSD</a><br />
</li><li> <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Nicotine">nicotine</a>, <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Cocaine">cocaine</a>, <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Amphetamine">amphetamine</a></p>
</li></ul>

<p><strong>Sources of recreational drugs</strong>
<ul><li> Most come from plants
</li><li> Drugs protected plants from herbivores</p>
</li></ul>

<p><strong>Cocaine in the test tube and Mechanisms of entry, exemplified by cocaine</strong>
<ul><li> Cocaine base is uncharged (free base or crack) which permeates membranes
</li><li> Cocaine is reprotonated, the charged form in the brain acts on the dopamine transporter</p>
</li></ul>

<p><strong>Routes into the body</strong>
<ul><li> The various routes include eating/drinking, inhaling, smoking, and injecting
</li><li> The best routes depend on the chemistry of the molecule.</p>
</li></ul>

<hr />
<h1> <span class="mw-headline" id="Targets_.2825.29">Targets (25)</span></h1>
<p><strong>Targets for Recreational Drugs</strong></p>
<p><strong>Knockout mice and one application for them</strong></p>
<p><strong>Knockout mice in pharmacology</strong></p>
<p><strong>Most recreational drugs act at low active concentration</strong>
<ul><li> 10 nM (very low active concentration) 
</li></ul>
- LSD
<ul><li> 1 uM (low active concentration)- this is 100 x LSD 
</li></ul>
-morphine-heroin, tetrahydrocannabinol, nicotine, cocaine, amphetamine &amp; derivatives, phencyclidine
<ul><li> 10 uM active concentration - this is 1,000 x LSD<br />
</li></ul>
- caffeine
<ul><li> 1 mM (higher active concentration) - this is 100,000 x LSD
</li></ul>
- ethanol </p>
<p>--  </p>
<h1> <span class="mw-headline" id="System_level_effects_.2826.29">System level effects (26)</span></h1>
<hr />
<h1> <span class="mw-headline" id="Components_of_Addiction._Animal_Models._.2827.29">Components of Addiction.   Animal Models. (27)</span></h1>
<hr />
<h1> <span class="mw-headline" id="Nicotine_Addiction_at_the_circuit_and_cellular_level:_.E2.80.9COutside-In.E2.80.9D_Mechanisms_.2828.29">Nicotine Addiction at the circuit and cellular level: “Outside-In” Mechanisms (28)</span></h1>
<hr />
<h1> <span class="mw-headline" id="Upregulation_via_.E2.80.9CInside-Out.E2.80.9D_Mechanisms_.2829.29">Upregulation via “Inside-Out” Mechanisms (29)</span></h1>
<hr />
<h1> <span class="mw-headline" id="Recent_Genetic_Data_.2830.29">Recent Genetic Data (30)</span></h1>
<hr />
<h1> <span class="mw-headline" id="Drugs_for_smoking_cessation.3B_Harm_Reduction_.2831.29">Drugs for smoking cessation; Harm Reduction (31)</span></h1>
<hr />

<!-- 
NewPP limit report
Preprocessor node count: 19/1000000
Post-expand include size: 0/2097152 bytes
Template argument size: 0/2097152 bytes
Expensive parser function count: 0/100
-->


</div><div class="printfooter">
Retrieved from "<a href="https://share.coursera.org/wiki/index.php?title=Drugsandbrain:Lecture_Notes_3&amp;oldid=6240">https://share.coursera.org/wiki/index.php?title=Drugsandbrain:Lecture_Notes_3&amp;oldid=6240</a>"</div>
					<div id='catlinks' class='catlinks catlinks-allhidden'></div>					<!-- end content -->
									</div>
			</div>